BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34799857)

  • 21. Fenugreek extract diosgenin and pure diosgenin inhibit the hTERT gene expression in A549 lung cancer cell line.
    Rahmati-Yamchi M; Ghareghomi S; Haddadchi G; Milani M; Aghazadeh M; Daroushnejad H
    Mol Biol Rep; 2014 Sep; 41(9):6247-52. PubMed ID: 24973886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells.
    Srinivasan S; Koduru S; Kumar R; Venguswamy G; Kyprianou N; Damodaran C
    Int J Cancer; 2009 Aug; 125(4):961-7. PubMed ID: 19384950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenugreek (Trigonella Foenum-Graecum) Seed Flour and Diosgenin Preserve Endothelium-Dependent Arterial Relaxation in a Rat Model of Early-Stage Metabolic Syndrome.
    Szabó K; Gesztelyi R; Lampé N; Kiss R; Remenyik J; Pesti-Asbóth G; Priksz D; Szilvássy Z; Juhász B
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the pharmacological activities and mechanisms of diosgenin.
    Chen Y; Tang YM; Yu SL; Han YW; Kou JP; Liu BL; Yu BY
    Chin J Nat Med; 2015 Aug; 13(8):578-87. PubMed ID: 26253490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells.
    Corbiere C; Liagre B; Terro F; Beneytout JL
    Cell Res; 2004 Jun; 14(3):188-96. PubMed ID: 15225412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis.
    Liu MJ; Wang Z; Ju Y; Wong RN; Wu QY
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):79-90. PubMed ID: 15372201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of diosgenin on experimentally induced benign prostatic hyperplasia in rats.
    Chen J; Zhang HF; Xiong CM; Ruan JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):806-810. PubMed ID: 27924509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential and research progress of diosgenin for lipid metabolism diseases.
    Zhang SZ; Liang PP; Feng YN; Yin GL; Sun FC; Ma CQ; Zhang FX
    Drug Dev Res; 2022 Dec; 83(8):1725-1738. PubMed ID: 36126194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synergistic apoptotic effect of the combination of diosgenin and TRAIL on non-small-cell lung cancer cell line A549 evaluated with the Chou-Talalay method].
    He Y; Wang JS; Zhang P; Zhang WJ; Huang QL; Hua ZC
    Yao Xue Xue Bao; 2013 Jan; 48(1):45-51. PubMed ID: 23600140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diosgenin inhibits the proliferation, migration and invasion of the optic nerve sheath meningioma cells via induction of mitochondrial-mediated apoptosis, autophagy and G0/G1 cell cycle arrest.
    Zhu X; Chen Z; Li X
    J BUON; 2020; 25(1):508-513. PubMed ID: 32277676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression.
    Chen PS; Shih YW; Huang HC; Cheng HW
    PLoS One; 2011; 6(5):e20164. PubMed ID: 21629786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of diosgenin derivatives as apoptosis inducers through mitochondria-related pathways.
    Ma L; Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
    Eur J Med Chem; 2021 May; 217():113361. PubMed ID: 33740546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diosgenin induces cell cycle arrest and apoptosis in HEL cells with increase in intracellular calcium level, activation of cPLA2 and COX-2 overexpression.
    Leger DY; Liagre B; Corbière C; Cook-Moreau J; Beneytout JL
    Int J Oncol; 2004 Sep; 25(3):555-62. PubMed ID: 15289856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of diosgenin in diabetes and diabetic complications.
    Gan Q; Wang J; Hu J; Lou G; Xiong H; Peng C; Zheng S; Huang Q
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105575. PubMed ID: 31899316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 and 5-lipoxygenase pathways in diosgenin-induced apoptosis in HT-29 and HCT-116 colon cancer cells.
    Lepage C; Liagre B; Cook-Moreau J; Pinon A; Beneytout JL
    Int J Oncol; 2010 May; 36(5):1183-91. PubMed ID: 20372792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diosgenin, a steroidal saponin, exhibits anticancer activity by attenuating lipid peroxidation via enhancing antioxidant defense system during NMU-induced breast carcinoma.
    Jagadeesan J; Nandakumar N; Rengarajan T; Balasubramanian MP
    J Environ Pathol Toxicol Oncol; 2012; 31(2):121-9. PubMed ID: 23216637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage.
    Mao Z; Han X; Chen D; Xu Y; Xu L; Yin L; Sun H; Qi Y; Fang L; Liu K; Peng J
    Br J Pharmacol; 2019 Apr; 176(7):919-937. PubMed ID: 30710454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases.
    Parama D; Boruah M; Yachna K; Rana V; Banik K; Harsha C; Thakur KK; Dutta U; Arya A; Mao X; Ahn KS; Kunnumakkara AB
    Life Sci; 2020 Nov; 260():118182. PubMed ID: 32781063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ca2+ Entry, Oxidative Stress, Ceramide and Suicidal Erythrocyte Death Following Diosgenin Treatment.
    Mischitelli M; Jemaà M; Almasry M; Faggio C; Lang F
    Cell Physiol Biochem; 2016; 39(4):1626-37. PubMed ID: 27626275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diosgenin Induces Apoptosis in HepG2 Cells through Generation of Reactive Oxygen Species and Mitochondrial Pathway.
    Kim DS; Jeon BK; Lee YE; Woo WH; Mun YJ
    Evid Based Complement Alternat Med; 2012; 2012():981675. PubMed ID: 22719792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.